Rolf Richter

Papers

Total Citations

H-Index

About

Rolf Richter is a clinical researcher whose work has advanced the diagnostic precision of gynecologic oncology, particularly in the challenging area of borderline ovarian tumors. His most cited study, "The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary" (2015), critically evaluates the utility of the CA125 biomarker—a standard tool in ovarian cancer screening—for distinguishing borderline malignancies from invasive carcinomas. By analyzing its sensitivity and specificity in this specific tumor subtype, Richter’s work provides clinicians with evidence-based guidance to reduce misdiagnosis and tailor surgical management. While his citation count reflects a focused, niche contribution, the study remains a reference point for researchers refining non-invasive diagnostic protocols. Richter’s research underscores the importance of validating established biomarkers in rare or borderline pathologies, offering a model for how targeted investigations can improve patient outcomes. His work is particularly valuable for trainees in gynecologic oncology seeking to understand the nuances of tumor classification and the limitations of current serum markers.